Clinical Trial Update: A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug Given With Canagliflozin In Adults With Type 2 Diabetes Mellitus Taking Metformin [Phase 2]

View source ↗

Summary

Pfizer conducted a Phase 2 6-week study to assess the safety and effect of an investigational drug given with canagliflozin in adults with Type 2 Diabetes on me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Investigational drug (name not disclosed)
• Invokana (canagliflozin) (canagliflozin)

Snippet

Sponsor: Pfizer | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: TERMINATED